Prescription and Over-the-Counter Drug Product List: 8/2005

 Prescription and Over-the-Counter Drug Product List 
24th Edition
Cumulative Supplement Number 8: August 2005


[Prescription - OTC]

NOTE: The format for the Monthly Additions/Deletions DrugProduct List has changed as of the July Cumulative Supplement (CS) of the 21stEdition to mirror the CS. Refer to the CS Preface section 1.5CUMULATIVE SUPPLEMENT LEGEND.



ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

        ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE          TABLET; ORAL            DARVOCET A500>D>   AB      AAIPHARMA                  500MG;100MG                             N76429 001  Sep 10, 2003    Aug  CAHN>A>   AB      XANODYNE PHARM             500MG;100MG                             N76429 001  Sep 10, 2003    Aug  CAHN        ALCLOMETASONE DIPROPIONATE          CREAM; TOPICAL            ALCLOMETASONE DIPROPIONATE>A>   AB      TARO                       0.05%                                   N76587 001  Sep 15, 2005    Aug  NEWA        ALLOPURINOL          TABLET; ORAL            ALLOPURINOL>A>   AB      APOTEX                     100MG                                   N77353 001  Sep 08, 2005    Aug  NEWA>A>   AB                                 300MG                                   N77353 002  Sep 08, 2005    Aug  NEWA        AMOXICILLIN; CLAVULANATE POTASSIUM          TABLET; ORAL            AMOXICILLIN AND CLAVULANATE POTASSIUM>A>   AB      SANDOZ                     250MG;EQ 125MG BASE                     N65189 001  Aug 23, 2005    Aug  NEWA            AUGMENTIN '250'>D>           GLAXOSMITHKLINE            250MG;EQ 125MG BASE                     N50564 001  Aug 06, 1984    Aug  CFTG>A>   AB                                 250MG;EQ 125MG BASE                     N50564 001  Aug 06, 1984    Aug  CFTG        AMPICILLIN/AMPICILLIN TRIHYDRATE          CAPSULE; ORAL            AMPICILLIN TRIHYDRATE>D>   AB      CONSOLIDATED               EQ 250MG BASE                           N61602 001                  Aug  DISC>A>         @                            EQ 250MG BASE                           N61602 001                  Aug  DISC>D>   AB                                 EQ 500MG BASE                           N61602 002                  Aug  DISC>A>         @                            EQ 500MG BASE                           N61602 002                  Aug  DISC>D>   AB      TEVA                       EQ 250MG BASE                           N61502 001                  Aug  DISC>A>         @                            EQ 250MG BASE                           N61502 001                  Aug  DISC>D>   AB                                 EQ 500MG BASE                           N61502 002                  Aug  DISC>A>         @                            EQ 500MG BASE                           N61502 002                  Aug  DISC>D>         TOTACILLIN>D>   AB      GLAXOSMITHKLINE            EQ 250MG BASE                           N62212 001                  Aug  DISC>A>         @                            EQ 250MG BASE                           N62212 001                  Aug  DISC>D>   AB                                 EQ 500MG BASE                           N62212 002                  Aug  DISC>A>         @                            EQ 500MG BASE                           N62212 002                  Aug  DISC          FOR SUSPENSION; ORAL            AMPICILLIN TRIHYDRATE>D>   AB      CONSOLIDATED               EQ 125MG BASE/5ML                       N61601 001                  Aug  DISC>A>         @                            EQ 125MG BASE/5ML                       N61601 001                  Aug  DISC>D>   AB                                 EQ 250MG BASE/5ML                       N61601 002                  Aug  DISC>A>         @                            EQ 250MG BASE/5ML                       N61601 002                  Aug  DISC>D>   AB      TEVA                       EQ 125MG BASE/5ML                       N61370 001                  Aug  DISC>A>         @                            EQ 125MG BASE/5ML                       N61370 001                  Aug  DISC>D>   AB                                 EQ 250MG BASE/5ML                       N61370 002                  Aug  DISC>A>         @                            EQ 250MG BASE/5ML                       N61370 002                  Aug  DISC        ARIPIPRAZOLE          TABLET; ORAL            ABILIFY>D>           OTSUKA                     2MG                                     N21436 006  Nov 15, 2002    Aug  DISC>A>         @                            2MG                                     N21436 006  Nov 15, 2002    Aug  DISC>D>                                      5MG                                     N21436 005  Nov 15, 2002    Aug  CRLD>A>       +                              5MG                                     N21436 005  Nov 15, 2002    Aug  CRLD>D>                                      15MG                                    N21436 002  Nov 15, 2002    Aug  CRLD>A>       +                              15MG                                    N21436 002  Nov 15, 2002    Aug  CRLD        ASPIRIN; PRAVASTATIN SODIUM>A>       TABLET, TABLET; ORAL>A>         PRAVIGARD PAC (COPACKAGED)>A>           BRISTOL MYERS              81MG,N/A;N/A,20MG                       N21387 001  Jun 24, 2003    Aug  CDFR>A>                                      81MG,N/A;N/A,40MG                       N21387 002  Jun 24, 2003    Aug  CDFR>A>                                      81MG,N/A;N/A,80MG                       N21387 003  Jun 24, 2003    Aug  CDFR>A>                                      325MG,N/A;N/A,20MG                      N21387 004  Jun 24, 2003    Aug  CDFR>A>                                      325MG,N/A;N/A,40MG                      N21387 005  Jun 24, 2003    Aug  CDFR>A>       +                              325MG,N/A;N/A,80MG                      N21387 006  Jun 24, 2003    Aug  CDFR>D>       TABLET; ORAL>D>         PRAVIGARD PAC (COPACKAGED)>D>           BRISTOL MYERS              81MG;20MG                               N21387 001  Jun 24, 2003    Aug  CDFR>D>                                      81MG;40MG                               N21387 002  Jun 24, 2003    Aug  CDFR>D>                                      81MG;80MG                               N21387 003  Jun 24, 2003    Aug  CDFR>D>                                      325MG;20MG                              N21387 004  Jun 24, 2003    Aug  CDFR>D>                                      325MG;40MG                              N21387 005  Jun 24, 2003    Aug  CDFR>D>       +                              325MG;80MG                              N21387 006  Jun 24, 2003    Aug  CDFR        BACLOFEN          TABLET; ORAL            BACLOFEN>A>   AB      VINTAGE PHARMS             10MG                                    N77156 001  Aug 30, 2005    Aug  NEWA>A>   AB                                 20MG                                    N77068 001  Aug 30, 2005    Aug  NEWA        BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE          TABLET; ORAL            BENAZEPRIL HCL AND HYDROCHLOROTHIAZIDE>A>   AB      RANBAXY                    5MG;6.25MG                              N77483 001  Sep 08, 2005    Aug  NEWA>A>   AB                                 10MG;12.5MG                             N77483 002  Sep 08, 2005    Aug  NEWA>A>   AB                                 20MG;12.5MG                             N77483 003  Sep 08, 2005    Aug  NEWA>A>   AB                                 20MG;25MG                               N77483 004  Sep 08, 2005    Aug  NEWA        BENZTROPINE MESYLATE          INJECTABLE; INJECTION            COGENTIN>D>       +   MERCK                      1MG/ML                                  N12015 001                  Aug  CAHN>A>       +   OVATION PHARMS             1MG/ML                                  N12015 001                  Aug  CAHN>D>     BEPRIDIL HYDROCHLORIDE>D>       TABLET; ORAL>D>         VASCOR>A>         @ JOHNSON AND                200MG                                   N19002 001  Dec 28, 1990    Aug  DISC>D>       +   ORTHO MCNEIL               200MG                                   N19002 001  Dec 28, 1990    Aug  DISC        BRIMONIDINE TARTRATE          SOLUTION/DROPS; OPHTHALMIC>A>         ALPHAGAN P>A>       +   ALLERGAN                   0.1%                                    N21770 001  Aug 19, 2005    Aug  NEWA        CAFFEINE; ERGOTAMINE TARTRATE          SUPPOSITORY; RECTAL            CAFERGOT>D>       +   NOVARTIS                   100MG;2MG                               N09000 002                  Aug  CTEC>A>   BR  +                              100MG;2MG                               N09000 002                  Aug  CTEC          TABLET; ORAL            ERGOTAMINE TARTRATE AND CAFFEINE>A>   AA      MIKART                     100MG;1MG                               N40590 001  Sep 16, 2005    Aug  NEWA>A>     CALCITONIN SALMON RECOMBINANT>A>       SPRAY, METERED; NASAL>A>         FORTICAL>A>       +   UNIGENE                    200 IU/SPRAY                            N21406 001  Aug 12, 2005    Aug  NEWA        CALCITONIN, SALMON          INJECTABLE; INJECTION>D>         CALCIMAR>D>   AP  +   AVENTIS                    200 IU/ML                               N17769 001                  Aug  DISC>A>         @                            200 IU/ML                               N17769 001                  Aug  DISC        CALCITRIOL          INJECTABLE; INJECTION            CALCITRIOL>D>   AP      AAIPHARMA LLC              0.001MG/ML                              N75766 001  Feb 20, 2003    Aug  CAHN>D>   AP                                 0.002MG/ML                              N75766 002  Feb 20, 2003    Aug  CAHN>A>   AP      XANODYNE PHARM             0.001MG/ML                              N75766 001  Feb 20, 2003    Aug  CAHN>A>   AP                                 0.002MG/ML                              N75766 002  Feb 20, 2003    Aug  CAHN>A>     CALCIUM CARBONATE; RISEDRONATE SODIUM>A>       TABLET, TABLET; ORAL>A>         ACTONEL WITH CALCIUM (COPACKAGED)>A>       +   PROCTER AND                EQ 500MG BASE,N/A;N/A,35MG              N21823 001  Aug 12, 2005    Aug  NEWA        CARBOPLATIN          INJECTABLE; IV (INFUSION)            CARBOPLATIN>D>   AP      MAYNE PHARMA USA           600MG/60ML (10MG/ML)                    N77059 001  Nov 23, 2004    Aug  CPOT>A>   AP                                 EQ 600MG/ML (10MG/ML)                   N77059 001  Nov 23, 2004    Aug  CPOT>A>   AP      SICOR PHARMS               EQ 50MG/5ML (10MG/ML)                   N77139 001  Sep 21, 2005    Aug  NEWA>A>   AP                                 EQ 150MG/15ML (10MG/ML)                 N77139 002  Sep 21, 2005    Aug  NEWA>A>   AP                                 EQ 450MG/45ML (10MG/ML)                 N77139 003  Sep 21, 2005    Aug  NEWA>A>   AP                                 EQ 600MG/60ML (10MG/ML)                 N77139 004  Sep 21, 2005    Aug  NEWA        CEFIXIME>D>       TABLET; ORAL>D>         SUPRAX>D>       +   LUPIN                      400MG                                   N65130 001  Feb 12, 2004    Aug  DISC>A>         @                            400MG                                   N65130 001  Feb 12, 2004    Aug  DISC        CEFTRIAXONE SODIUM          INJECTABLE; INJECTION            CEFTRIAXONE IN PLASTIC CONTAINER>A>   AP      BAXTER HLTHCARE            EQ 20MG BASE/ML                         N65224 001  Aug 23, 2005    Aug  NEWA>A>   AP                                 EQ 40MG BASE/ML                         N65224 002  Aug 23, 2005    Aug  NEWA            ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER>D>       +   HLR                        EQ 20MG BASE/ML                         N50624 002  Feb 11, 1987    Aug  CFTG>A>   AP  +                              EQ 20MG BASE/ML                         N50624 002  Feb 11, 1987    Aug  CFTG>D>       +                              EQ 40MG BASE/ML                         N50624 003  Feb 11, 1987    Aug  CFTG>A>   AP  +                              EQ 40MG BASE/ML                         N50624 003  Feb 11, 1987    Aug  CFTG        CHLOROTHIAZIDE          TABLET; ORAL            DIURIL>D>         @ MERCK                      250MG                                   N11145 004                  Aug  CAHN>D>         @                            500MG                                   N11145 002                  Aug  CAHN>A>         @ OVATION PHARMS             250MG                                   N11145 004                  Aug  CAHN>A>         @                            500MG                                   N11145 002                  Aug  CAHN        CHLOROTHIAZIDE SODIUM          INJECTABLE; INJECTION            DIURIL>D>       +   MERCK                      EQ 500MG BASE/VIAL                      N11145 005                  Aug  CAHN>A>       +   OVATION PHARMS             EQ 500MG BASE/VIAL                      N11145 005                  Aug  CAHN        CHOLESTYRAMINE          POWDER; ORAL            CHOLESTYRAMINE>A>   AB      PAR PHARM                  EQ 4GM RESIN/PACKET                     N77204 001  Aug 26, 2005    Aug  NEWA>A>   AB                                 EQ 4GM RESIN/SCOOPFUL                   N77204 002  Aug 26, 2005    Aug  NEWA            CHOLESTYRAMINE LIGHT>A>   AB      PAR PHARM                  EQ 4GM RESIN/PACKET                     N77203 001  Aug 26, 2005    Aug  NEWA>A>   AB                                 EQ 4GM RESIN/SCOOPFUL                   N77203 002  Aug 26, 2005    Aug  NEWA        CLARITHROMYCIN          TABLET, EXTENDED RELEASE; ORAL            CLARITHROMYCIN EXTENDED RELEASE>A>   AB      SANDOZ                     500MG                                   N65250 001  Aug 25, 2005    Aug  NEWA          TABLET; ORAL            CLARITHROMYCIN>A>   AB      SANDOZ                     500MG                                   N65136 001  Aug 25, 2005    Aug  NEWA        CLOZAPINE          TABLET; ORAL            CLOZAPINE>A>   AB      CARACO                     50MG                                    N75713 003  Aug 19, 2005    Aug  NEWA>D>           IVAX PHARMS                50MG                                    N74949 004  Apr 25, 2005    Aug  CTEC>A>   AB                                 50MG                                    N74949 004  Apr 25, 2005    Aug  CTEC>D>   AB  +                              100MG                                   N74949 002  Nov 26, 1997    Aug  CRLD>A>   AB                                 100MG                                   N74949 002  Nov 26, 1997    Aug  CRLD            CLOZARIL>D>   AB      NOVARTIS                   100MG                                   N19758 002  Sep 26, 1989    Aug  CRLD>A>   AB  +                              100MG                                   N19758 002  Sep 26, 1989    Aug  CRLD        DACTINOMYCIN          INJECTABLE; INJECTION            COSMEGEN>D>       +   MERCK                      0.5MG/VIAL                              N50682 001                  Aug  CAHN>A>       +   OVATION PHARMS             0.5MG/VIAL                              N50682 001                  Aug  CAHN        DICLOFENAC SODIUM          TABLET, DELAYED RELEASE; ORAL            DICLOFENAC SODIUM>D>   AB      SANDOZ                     25MG                                    N74376 001  Sep 28, 1995    Aug  CRLD>A>   AB  +                              25MG                                    N74376 001  Sep 28, 1995    Aug  CRLD>D>   AB                                 50MG                                    N74376 002  Sep 28, 1995    Aug  CRLD>A>   AB  +                              50MG                                    N74376 002  Sep 28, 1995    Aug  CRLD>D>   AB                                 75MG                                    N74394 001  Nov 30, 1995    Aug  CRLD>A>   AB  +                              75MG                                    N74394 001  Nov 30, 1995    Aug  CRLD>D>         VOLTAREN>D>   AB  +   NOVARTIS                   75MG                                    N19201 003  Jul 28, 1988    Aug  DISC>A>         @                            75MG                                    N19201 003  Jul 28, 1988    Aug  DISC        ENOXAPARIN SODIUM          INJECTABLE; SUBCUTANEOUS>D>         LOVENOX>D>       +   AVENTIS                    30MG/0.3ML                              N20164 001  Mar 29, 1993    Aug  CTNA>D>       +                              40MG/0.4ML                              N20164 002  Jan 30, 1998    Aug  CTNA>D>       +                              60MG/0.6ML                              N20164 003  Mar 27, 1998    Aug  CTNA>D>       +                              80MG/0.8ML                              N20164 004  Mar 27, 1998    Aug  CTNA>D>         @                            90MG/0.6ML                              N20164 006  Jun 02, 2000    Aug  CTNA>D>       +                              100MG/ML                                N20164 005  Mar 27, 1998    Aug  CTNA>D>       +                              120MG/0.8ML                             N20164 007  Jun 02, 2000    Aug  CTNA>D>       +                              150MG/ML                                N20164 008  Jun 02, 2000    Aug  CTNA>D>       +                              300MG/3ML                               N20164 009  Jan 23, 2003    Aug  CPOT>A>       +                              300MG/3ML (100MG/ML)                    N20164 009  Jan 23, 2003    Aug  CPOT>A>         LOVENOX (PRESERVATIVE FREE)>A>       +   AVENTIS                    30MG/0.3ML (100MG/ML)                   N20164 001  Mar 29, 1993    Aug  CTNA>A>       +                              40MG/0.4ML (100MG/ML)                   N20164 002  Jan 30, 1998    Aug  CTNA>A>       +                              60MG/0.6ML (100MG/ML)                   N20164 003  Mar 27, 1998    Aug  CTNA>A>       +                              80MG/0.8ML (100MG/ML)                   N20164 004  Mar 27, 1998    Aug  CTNA>A>         @                            90MG/0.6ML (150MG/ML)                   N20164 006  Jun 02, 2000    Aug  CTNA>A>       +                              100MG/ML (100MG/ML)                     N20164 005  Mar 27, 1998    Aug  CTNA>A>       +                              120MG/0.8ML (150MG/ML)                  N20164 007  Jun 02, 2000    Aug  CTNA>A>       +                              150 MG/ML (150 MG/ML)                   N20164 008  Jun 02, 2000    Aug  CTNA        EPINEPHRINE; LIDOCAINE HYDROCHLORIDE          SOLUTION; IONTOPHORESIS>D>         IONTOCAINE>D>       +   IOMED                      0.01MG/ML;2%                            N20530 001  Dec 21, 1995    Aug  DISC>A>         @                            0.01MG/ML;2%                            N20530 001  Dec 21, 1995    Aug  DISC        ETHINYL ESTRADIOL; LEVONORGESTREL          TABLET; ORAL-21>D>         AVIANE-21>D>       +   DURAMED PHARMS             0.02MG;0.1MG                            N75796 002  Apr 30, 2001    Aug  DISC>A>         @                            0.02MG;0.1MG                            N75796 002  Apr 30, 2001    Aug  DISC>D>         ENPRESSE-21>D>   AB      DURAMED PHARMS             0.03MG,0.05MG,0.075MG;0.04MG,0.03M      N75809 001  Jul 16, 2001    Aug  DISC                                         G,0.125MG>A>         @                            0.03MG,0.05MG,0.075MG;0.04MG,0.03M      N75809 001  Jul 16, 2001    Aug  DISC                                         G,0.125MG>D>         LESSINA-21>D>   AB2     BARR                       0.02MG;0.1MG                            N75803 001  Mar 20, 2002    Aug  DISC>A>         @                            0.02MG;0.1MG                            N75803 001  Mar 20, 2002    Aug  DISC>D>         LEVLITE>D>   AB2 +   BERLEX                     0.02MG;0.1MG                            N20860 001  Jul 13, 1998    Aug  DISC>A>         @                            0.02MG;0.1MG                            N20860 001  Jul 13, 1998    Aug  DISC>D>         LEVONORGESTREL AND ETHINYL ESTRADIOL>D>   AB1     BARR                       0.02MG;0.1MG                            N75862 001  Apr 29, 2003    Aug  DISC>A>         @                            0.02MG;0.1MG                            N75862 001  Apr 29, 2003    Aug  DISC>D>         LEVORA 0.15/30-21>D>   AB      WATSON LABS                0.03MG;0.15MG                           N73592 001  Dec 13, 1993    Aug  DISC>A>         @                            0.03MG;0.15MG                           N73592 001  Dec 13, 1993    Aug  DISC>D>         PORTIA-21>D>   AB      BARR                       0.03MG;0.15MG                           N75866 001  May 23, 2002    Aug  DISC>A>         @                            0.03MG;0.15MG                           N75866 001  May 23, 2002    Aug  DISC>D>         TRIVORA-21>D>   AB      WATSON LABS                0.03MG,0.04MG,0.03MG;0.05MG,0.075M      N74538 001  Dec 18, 1997    Aug  DISC                                         G,0.125MG>A>         @                            0.03MG,0.04MG,0.03MG;0.05MG,0.075M      N74538 001  Dec 18, 1997    Aug  DISC                                         G,0.125MG        FENOFIBRATE          CAPSULE; ORAL            ANTARA (MICRONIZED)>D>           RELIANT PHARMS             87MG                                    N21695 002  Nov 30, 2004    Aug  DISC>A>         @                            87MG                                    N21695 002  Nov 30, 2004    Aug  DISC        FENTANYL CITRATE>D>       TROCHE/LOZENGE; ORAL>D>         ACTIQ>D>           CEPHALON                   EQ 0.2MG BASE                           N20747 001  Nov 04, 1998    Aug  CDFR>D>       +                              EQ 0.4MG BASE                           N20747 002  Nov 04, 1998    Aug  CDFR>D>                                      EQ 0.6MG BASE                           N20747 003  Nov 04, 1998    Aug  CDFR>D>                                      EQ 0.8MG BASE                           N20747 004  Nov 04, 1998    Aug  CDFR>D>                                      EQ 1.2MG BASE                           N20747 005  Nov 04, 1998    Aug  CDFR>D>                                      EQ 1.6MG BASE                           N20747 006  Nov 04, 1998    Aug  CDFR>A>       TROCHE/LOZENGE; TRANSMUCOSAL>A>         ACTIQ>A>           CEPHALON                   EQ 0.2MG BASE                           N20747 001  Nov 04, 1998    Aug  CDFR>A>       +                              EQ 0.4MG BASE                           N20747 002  Nov 04, 1998    Aug  CDFR>A>                                      EQ 0.6MG BASE                           N20747 003  Nov 04, 1998    Aug  CDFR>A>                                      EQ 0.8MG BASE                           N20747 004  Nov 04, 1998    Aug  CDFR>A>                                      EQ 1.2MG BASE                           N20747 005  Nov 04, 1998    Aug  CDFR>A>                                      EQ 1.6MG BASE                           N20747 006  Nov 04, 1998    Aug  CDFR        FEXOFENADINE HYDROCHLORIDE          TABLET; ORAL            ALLEGRA>D>           AVENTIS PHARMS             30MG                                    N20872 001  Feb 25, 2000    Aug  CFTG>A>   AB                                 30MG                                    N20872 001  Feb 25, 2000    Aug  CFTG>D>                                      60MG                                    N20872 002  Feb 25, 2000    Aug  CFTG>A>   AB                                 60MG                                    N20872 002  Feb 25, 2000    Aug  CFTG>D>       +                              180MG                                   N20872 004  Feb 25, 2000    Aug  CFTG>A>   AB  +                              180MG                                   N20872 004  Feb 25, 2000    Aug  CFTG>A>         FEXOFENADINE HCL>A>   AB      BARR                       30MG                                    N76191 001  Aug 31, 2005    Aug  NEWA>A>   AB                                 60MG                                    N76191 002  Aug 31, 2005    Aug  NEWA>A>   AB                                 180MG                                   N76191 003  Aug 31, 2005    Aug  NEWA>A>   AB      TEVA                       30MG                                    N76447 001  Sep 01, 2005    Aug  NEWA>A>   AB                                 60MG                                    N76447 002  Sep 01, 2005    Aug  NEWA>A>   AB                                 180MG                                   N76447 003  Sep 01, 2005    Aug  NEWA        FLUCONAZOLE          INJECTABLE; INJECTION            FLUCONAZOLE IN SODIUM CHLORIDE 0.9%>A>   AP      WESTWOOD PHARM             200MG/100ML                             N76736 001  Aug 23, 2005    Aug  NEWA        FLUDEOXYGLUCOSE F-18          INJECTABLE; INTRAVENOUS            FLUDEOXYGLUCOSE F18>A>       +   NORTH SHORE LIJ            20-200mCi/ML                            N21870 001  Aug 19, 2005    Aug  NEWA        FOLLITROPIN ALFA/BETA          INJECTABLE; SUBCUTANEOUS            FOLLISTIM AQ>A>       +   ORGANON USA INC            75 IU/0.5ML                             N21273 001  Aug 26, 2005    Aug  NEWA>A>       +                              150 IU/0.5ML                            N21273 002  Aug 26, 2005    Aug  NEWA            GONAL-F>D>           SERONO INC                 450 IU/VIAL                             N20378 005  Mar 26, 2004    Aug  CRLD>A>       +                              450 IU/VIAL                             N20378 005  Mar 26, 2004    Aug  CRLD            GONAL-F RFF PEN>D>           SERONO INC                 300 IU/0.5ML                            N21684 001  May 25, 2004    Aug  CRLD>A>       +                              300 IU/0.5ML                            N21684 001  May 25, 2004    Aug  CRLD>D>                                      450 IU/0.75ML                           N21684 002  May 25, 2004    Aug  CRLD>A>       +                              450 IU/0.75ML                           N21684 002  May 25, 2004    Aug  CRLD        FUROSEMIDE          SOLUTION; ORAL            FUROSEMIDE>D>   AA      ROXANE                     10MG/ML                                 N70434 001  Apr 22, 1987    Aug  CRLD>A>   AA  +                              10MG/ML                                 N70434 001  Apr 22, 1987    Aug  CRLD>D>         LASIX>D>   AA  +   AVENTIS PHARMS             10MG/ML                                 N17688 001                  Aug  DISC>A>         @                            10MG/ML                                 N17688 001                  Aug  DISC        GABAPENTIN          TABLET; ORAL            GABAPENTIN>A>   AB      RANBAXY                    600MG                                   N76605 001  Sep 14, 2005    Aug  NEWA>A>   AB                                 800MG                                   N76605 002  Sep 14, 2005    Aug  NEWA        GALANTAMINE HYDROBROMIDE          CAPSULE, EXTENDED RELEASE; ORAL>A>         RAZADYNE ER>A>       +   JANSSEN                    EQ 8MG BASE                             N21615 001  Dec 22, 2004    Aug  CTNA>A>                                      EQ 16MG BASE                            N21615 002  Dec 22, 2004    Aug  CTNA>A>                                      EQ 24MG BASE                            N21615 003  Dec 22, 2004    Aug  CTNA>D>         REMINYL>D>       +   JOHNSON AND                EQ 8MG BASE                             N21615 001  Dec 22, 2004    Aug  CTNA>D>                                      EQ 16MG BASE                            N21615 002  Dec 22, 2004    Aug  CTNA>D>                                      EQ 24MG BASE                            N21615 003  Dec 22, 2004    Aug  CTNA          SOLUTION; ORAL>A>         RAZADYNE>A>       +   JANSSEN PHARMA             4MG/ML                                  N21224 001  Jun 22, 2001    Aug  CTNA>D>         REMINYL>D>       +   JANSSEN PHARMA             4MG/ML                                  N21224 001  Jun 22, 2001    Aug  CTNA          TABLET; ORAL>A>         RAZADYNE>A>       +   JANSSEN PHARMA             EQ 4MG BASE                             N21169 001  Feb 28, 2001    Aug  CTNA>A>                                      EQ 8MG BASE                             N21169 002  Feb 28, 2001    Aug  CTNA>A>                                      EQ 12MG BASE                            N21169 003  Feb 28, 2001    Aug  CTNA>D>         REMINYL>D>       +   JANSSEN PHARMA             EQ 4MG BASE                             N21169 001  Feb 28, 2001    Aug  CTNA>D>                                      EQ 8MG BASE                             N21169 002  Feb 28, 2001    Aug  CTNA>D>                                      EQ 12MG BASE                            N21169 003  Feb 28, 2001    Aug  CTNA        INDOMETHACIN SODIUM          INJECTABLE; INJECTION            INDOCIN I.V.>D>       +   MERCK                      EQ 1MG BASE/VIAL                        N18878 001  Jan 30, 1985    Aug  CAHN>A>       +   OVATION PHARMS             EQ 1MG BASE/VIAL                        N18878 001  Jan 30, 1985    Aug  CAHN        LEFLUNOMIDE          TABLET; ORAL            ARAVA>D>           AVENTIS PHARMS             10MG                                    N20905 001  Sep 10, 1998    Aug  CFTG>A>   AB                                 10MG                                    N20905 001  Sep 10, 1998    Aug  CFTG>D>       +                              20MG                                    N20905 002  Sep 10, 1998    Aug  CFTG>A>   AB  +                              20MG                                    N20905 002  Sep 10, 1998    Aug  CFTG>A>         LEFLUNOMIDE>A>   AB      APOTEX                     10MG                                    N77090 001  Sep 13, 2005    Aug  NEWA>A>   AB                                 20MG                                    N77090 002  Sep 13, 2005    Aug  NEWA>A>   AB      BARR                       10MG                                    N77083 001  Sep 13, 2005    Aug  NEWA>A>   AB                                 20MG                                    N77083 002  Sep 13, 2005    Aug  NEWA>A>   AB      KALI LABS                  10MG                                    N77086 001  Sep 13, 2005    Aug  NEWA>A>   AB                                 20MG                                    N77086 002  Sep 13, 2005    Aug  NEWA>A>   AB      SANDOZ                     10MG                                    N77087 001  Sep 13, 2005    Aug  NEWA>A>   AB                                 10MG                                    N77085 001  Sep 13, 2005    Aug  NEWA>A>   AB                                 20MG                                    N77087 002  Sep 13, 2005    Aug  NEWA>A>   AB                                 20MG                                    N77085 002  Sep 13, 2005    Aug  NEWA>A>   AB      TEVA PHARMS                10MG                                    N77084 001  Sep 13, 2005    Aug  NEWA>A>   AB                                 20MG                                    N77084 002  Sep 13, 2005    Aug  NEWA        LIDOCAINE HYDROCHLORIDE          INJECTABLE; SPINAL>D>         XYLOCAINE 1.5% W/ DEXTROSE 7.5%>D>       +   ASTRAZENECA                1.5%                                    N16297 001                  Aug  DISC>A>         @                            1.5%                                    N16297 001                  Aug  DISC        LIOTHYRONINE SODIUM          INJECTABLE; INJECTION>A>         LIOTHYRONINE SODIUM>A>   AP      PHARMAFORCE                EQ 0.01MG BASE/ML                       N76923 001  Aug 17, 2005    Aug  NEWA            TRIOSTAT>D>       +   JONES PHARMA               EQ 0.01MG BASE/ML                       N20105 001  Dec 31, 1991    Aug  CFTG>A>   AP  +                              EQ 0.01MG BASE/ML                       N20105 001  Dec 31, 1991    Aug  CFTG        LISINOPRIL          TABLET; ORAL            LISINOPRIL>A>   AB      LUPIN                      2.5MG                                   N77321 001  Sep 09, 2005    Aug  NEWA>A>   AB                                 5MG                                     N77321 002  Sep 09, 2005    Aug  NEWA>A>   AB                                 10MG                                    N77321 003  Sep 09, 2005    Aug  NEWA>A>   AB                                 20MG                                    N77321 004  Sep 09, 2005    Aug  NEWA>A>   AB                                 30MG                                    N77321 005  Sep 09, 2005    Aug  NEWA>A>   AB                                 40MG                                    N77321 006  Sep 09, 2005    Aug  NEWA>A>     MECASERMIN RECOMBINANT>A>       INJECTABLE; SUBCUTANEOUS>A>         INCRELEX>A>       +   TERCICA                    40MG/4ML(10MG/ML)                       N21839 001  Aug 30, 2005    Aug  NEWA        MECHLORETHAMINE HYDROCHLORIDE          INJECTABLE; INJECTION            MUSTARGEN>D>       +   MERCK                      10MG/VIAL                               N06695 001                  Aug  CAHN>A>       +   OVATION PHARMS             10MG/VIAL                               N06695 001                  Aug  CAHN        METFORMIN HYDROCHLORIDE          TABLET, EXTENDED RELEASE; ORAL            METFORMIN HCL>A>   AB      IMPAX LABS                 750MG                                   N76985 001  Sep 13, 2005    Aug  NEWA>A>   AB      MYLAN                      500MG                                   N76650 001  Sep 13, 2005    Aug  NEWA>A>   AB                                 750MG                                   N77113 001  Sep 08, 2005    Aug  NEWA>A>     METFORMIN; PIOGLITAZONE HYDROCHLORIDE>A>       TABLET; ORAL>A>         ACTOPLUS MET>A>           TAKEDA GLOBAL              500MG;EQ 15MG BASE                      N21842 001  Aug 29, 2005    Aug  NEWA>A>       +                              850MG;EQ 15MG BASE                      N21842 002  Aug 29, 2005    Aug  NEWA        METOCLOPRAMIDE HYDROCHLORIDE          TABLET, ORALLY DISINTEGRATING; ORAL>D>         METOCLOPRAMIDE>D>           SCHWARZ PHARMA             EQ 5MG BASE                             N21793 001  Jun 10, 2005    Aug  CTNA>D>       +                              EQ 10MG BASE                            N21793 002  Jun 10, 2005    Aug  CTNA>A>         REGLAN ODT>A>           SCHWARZ PHARMA             EQ 5MG BASE                             N21793 001  Jun 10, 2005    Aug  CTNA>A>       +                              EQ 10MG BASE                            N21793 002  Jun 10, 2005    Aug  CTNA        MIDAZOLAM HYDROCHLORIDE          SYRUP; ORAL            MIDAZOLAM HCL>A>   AA      APOTEX                     EQ 2MG BASE/ML                          N77115 001  Sep 09, 2005    Aug  NEWA        MIRTAZAPINE          TABLET, ORALLY DISINTEGRATING; ORAL            MIRTAZAPINE>A>   AB      AMIDE PHARM                15MG                                    N76689 001  Aug 31, 2005    Aug  NEWA>A>   AB                                 30MG                                    N76689 002  Aug 31, 2005    Aug  NEWA>A>   AB                                 45MG                                    N76689 003  Aug 31, 2005    Aug  NEWA>A>     NEPAFENAC>A>       SUSPENSION/DROPS; OPHTHALMIC>A>         NEVANAC>A>       +   ALCON                      0.1%                                    N21862 001  Aug 19, 2005    Aug  NEWA        NIZATIDINE          CAPSULE; ORAL            NIZATIDINE>A>   AB      DR REDDYS LABS LTD         150MG                                   N77314 001  Sep 15, 2005    Aug  NEWA>A>   AB                                 300MG                                   N77314 002  Sep 15, 2005    Aug  NEWA        ORPHENADRINE CITRATE          TABLET, EXTENDED RELEASE; ORAL>D>         NORFLEX>D>   AB  +   3M                         100MG                                   N12157 001                  Aug  DISC>A>         @                            100MG                                   N12157 001                  Aug  DISC            ORPHENADRINE CITRATE>D>   AB      EON                        100MG                                   N40327 001  Feb 15, 2000    Aug  CRLD>A>   AB  +   SANDOZ                     100MG                                   N40327 001  Feb 15, 2000    Aug  CRLD        PHENYTOIN          SUSPENSION; ORAL            PHENYTOIN>A>   AB      VISTAPHARM                 125MG/5ML                               N40610 001  Aug 18, 2005    Aug  NEWA        PREDNISOLONE          SYRUP; ORAL            PREDISOLONE>A>   AA      APOTEX                     15MG/5ML                                N40571 001  Aug 25, 2005    Aug  NEWA            PREDNISOLONE>A>   AA      APOTEX                     5MG/5ML                                 N40570 001  Aug 25, 2005    Aug  NEWA>D>       +   KV PHARM                   5MG/5ML                                 N40423 001  Oct 22, 2001    Aug  CTEC>A>   AA  +                              5MG/5ML                                 N40423 001  Oct 22, 2001    Aug  CTEC        PROCAINAMIDE HYDROCHLORIDE          TABLET, EXTENDED RELEASE; ORAL            PROCAINAMIDE HCL>D>   AB      COPLEY PHARM               500MG                                   N88974 001  Jul 22, 1985    Aug  DISC>A>         @                            500MG                                   N88974 001  Jul 22, 1985    Aug  DISC>D>   AB                                 750MG                                   N89438 001  Mar 23, 1987    Aug  DISC>A>         @                            750MG                                   N89438 001  Mar 23, 1987    Aug  DISC>D>   AB                                 1GM                                     N40111 001  Dec 13, 1996    Aug  DISC>A>         @                            1GM                                     N40111 001  Dec 13, 1996    Aug  DISC        PROMETHAZINE HYDROCHLORIDE          TABLET; ORAL            PHENERGAN>D>       +   WYETH PHARMS INC           25MG                                    N07935 003                  Aug  CTEC>A>   BP  +                              25MG                                    N07935 003                  Aug  CTEC        QUETIAPINE FUMARATE          TABLET; ORAL            SEROQUEL>D>           ASTRAZENECA                EQ 150MG BASE                           N20639 004  Dec 20, 1998    Aug  DISC>A>         @                            EQ 150MG BASE                           N20639 004  Dec 20, 1998    Aug  DISC        QUINAPRIL HYDROCHLORIDE          TABLET; ORAL            QUINAPRIL HCL>A>   AB      GENPHARM                   EQ 5MG BASE                             N76036 001  Jan 28, 2005    Aug  CAHN>A>   AB                                 EQ 10MG BASE                            N76036 002  Jan 28, 2005    Aug  CAHN>A>   AB                                 EQ 20MG BASE                            N76036 003  Jan 28, 2005    Aug  CAHN>A>   AB                                 EQ 40MG BASE                            N76036 004  Jan 28, 2005    Aug  CAHN>D>   AB      PAR PHARM                  EQ 5MG BASE                             N76036 001  Jan 28, 2005    Aug  CAHN>D>   AB                                 EQ 10MG BASE                            N76036 002  Jan 28, 2005    Aug  CAHN>D>   AB                                 EQ 20MG BASE                            N76036 003  Jan 28, 2005    Aug  CAHN>D>   AB                                 EQ 40MG BASE                            N76036 004  Jan 28, 2005    Aug  CAHN        QUININE SULFATE>A>       CAPSULE; ORAL>A>         QUININE SULFATE>A>       +   MUTUAL PHARM               324MG                                   N21799 001  Aug 12, 2005    Aug  NEWA        RIVASTIGMINE TARTRATE          CAPSULE; ORAL            EXELON>D>           NOVARTIS                   EQ 1.5MG BASE                           N20823 003  Apr 21, 2000    Aug  CRLD>A>       +                              EQ 1.5MG BASE                           N20823 003  Apr 21, 2000    Aug  CRLD        TECHNETIUM TC-99M PENTETATE KIT          INJECTABLE; INJECTION            MPI DTPA KIT - CHELATE>D>         @ GE HEALTHCARE              N/A                                     N17255 001                  Aug  CMFD>A>   AP                                 N/A                                     N17255 001                  Aug  CMFD        TRAMADOL HYDROCHLORIDE          TABLET, ORALLY DISINTEGRATING; ORAL>A>         TRAMADOL HCL>A>       +   BIOVAIL                    50MG                                    N21693 001  May 05, 2005    Aug  CTNA>D>         TRAMADOL HYDROCLORIDE>D>       +   BIOVAIL                    50MG                                    N21693 001  May 05, 2005    Aug  CTNA        TRETINOIN          CREAM; TOPICAL            RENOVA>D>       +   JOHNSON AND                0.05%                                   N19963 001  Dec 29, 1995    Aug  CFTG>A>   AB2 +                              0.05%                                   N19963 001  Dec 29, 1995    Aug  CFTG            RETIN-A>D>   AB  +   JOHNSON AND                0.05%                                   N17522 001                  Aug  CTEC>A>   AB1 +                              0.05%                                   N17522 001                  Aug  CTEC>A>         TRETINOIN>A>   AB2     SPEAR PHARMS               0.05%                                   N76498 001  Sep 15, 2005    Aug  NEWA>D>   AB                                 0.05%                                   N75265 001  Dec 24, 1998    Aug  CTEC>A>   AB1                                0.05%                                   N75265 001  Dec 24, 1998    Aug  CTEC        TRIMETHOPRIM HYDROCHLORIDE          SOLUTION; ORAL            PRIMSOL>A>         @ FSC                        EQ 25MG BASE/5ML                        N74374 001  Jun 23, 1995    Aug  CAHN>A>       +                              EQ 50MG BASE/5ML                        N74973 001  Jan 24, 2000    Aug  CAHN>D>         @ TARO PHARMS NORTH          EQ 25MG BASE/5ML                        N74374 001  Jun 23, 1995    Aug  CAHN>D>       +                              EQ 50MG BASE/5ML                        N74973 001  Jan 24, 2000    Aug  CAHN        VANCOMYCIN HYDROCHLORIDE          INJECTABLE; INJECTION>D>         VANCOLED>D>   AP  +   BAXTER HLTHCARE            EQ 500MG BASE/VIAL                      N62682 001  Jul 22, 1986    Aug  DISC>A>         @                            EQ 500MG BASE/VIAL                      N62682 001  Jul 22, 1986    Aug  DISC>D>   AP  +                              EQ 1GM BASE/VIAL                        N62682 002  Mar 30, 1988    Aug  DISC>A>         @                            EQ 1GM BASE/VIAL                        N62682 002  Mar 30, 1988    Aug  DISC>D>       +                              EQ 2GM BASE/VIAL                        N62682 003  May 11, 1988    Aug  DISC>A>         @                            EQ 2GM BASE/VIAL                        N62682 003  May 11, 1988    Aug  DISC>D>   AP  +                              EQ 5GM BASE/VIAL                        N62682 004  May 11, 1988    Aug  DISC>A>         @                            EQ 5GM BASE/VIAL                        N62682 004  May 11, 1988    Aug  DISC>D>   AP  +                              EQ 10GM BASE/VIAL                       N62682 005  May 11, 1988    Aug  DISC>A>         @                            EQ 10GM BASE/VIAL                       N62682 005  May 11, 1988    Aug  DISC            VANCOMYCIN HCL>D>   AP      AM PHARM PARTNERS          EQ 500MG BASE/VIAL                      N62663 001  Mar 17, 1987    Aug  CRLD>A>   AP  +   AM PHARM PARTNERS          EQ 500MG BASE/VIAL                      N62663 001  Mar 17, 1987    Aug  CRLD>D>   AP                                 EQ 1GM BASE/VIAL                        N62663 002  Jul 31, 1987    Aug  CRLD>A>   AP  +                              EQ 1GM BASE/VIAL                        N62663 002  Jul 31, 1987    Aug  CRLD>D>   AP                                 EQ 5GM BASE/VIAL                        N62663 003  Jun 03, 1988    Aug  CRLD>A>   AP  +                              EQ 5GM BASE/VIAL                        N62663 003  Jun 03, 1988    Aug  CRLD>D>   AP                                 EQ 10GM BASE/VIAL                       N62663 004  Nov 28, 1997    Aug  CRLD>A>       +                              EQ 10GM BASE/VIAL                       N62663 004  Nov 28, 1997    Aug  CRLD>D>   AP      HOSPIRA                    EQ 500MG BASE/VIAL                      N62931 001  Oct 29, 1992    Aug  CRLD>A>   AP  +                              EQ 500MG BASE/VIAL                      N62931 001  Oct 29, 1992    Aug  CRLD>D>   AP                                 EQ 500MG BASE/VIAL                      N62911 001  Aug 04, 1988    Aug  CRLD>A>   AP  +                              EQ 500MG BASE/VIAL                      N62911 001  Aug 04, 1988    Aug  CRLD>D>   AP                                 EQ 1GM BASE/VIAL                        N62933 001  Oct 29, 1992    Aug  CRLD>A>   AP  +                              EQ 1GM BASE/VIAL                        N62933 001  Oct 29, 1992    Aug  CRLD>D>   AP                                 EQ 1GM BASE/VIAL                        N62912 001  Aug 04, 1988    Aug  CRLD>A>   AP  +                              EQ 1GM BASE/VIAL                        N62912 001  Aug 04, 1988    Aug  CRLD>D>   AP                                 EQ 5GM BASE/VIAL                        N63076 001  Dec 21, 1990    Aug  CRLD>A>   AP  +                              EQ 5GM BASE/VIAL                        N63076 001  Dec 21, 1990    Aug  CRLD        ZIDOVUDINE          SYRUP; ORAL            RETROVIR>D>       +   GLAXOSMITHKLINE            50MG/5ML                                N19910 001  Sep 28, 1989    Aug  CFTG>A>   AA  +                              50MG/5ML                                N19910 001  Sep 28, 1989    Aug  CFTG>A>         ZIDOVUDINE>A>   AA      AUROBINDO                  50MG/5ML                                N77268 001  Sep 19, 2005    Aug  NEWA          TABLET; ORAL            RETROVIR>D>       +   GLAXOSMITHKLINE            300MG                                   N20518 002  Oct 04, 1996    Aug  CFTG>A>   AB  +                              300MG                                   N20518 002  Oct 04, 1996    Aug  CFTG>A>         ZIDOVUDINE>A>   AB      AUROBINDO                  300MG                                   N77267 001  Sep 19, 2005    Aug  NEWA>A>   AB      RANBAXY                    300MG                                   N77327 001  Sep 19, 2005    Aug  NEWA>A>   AB      ROXANE                     300MG                                   N76844 001  Sep 19, 2005    Aug  NEWA

ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

   
>D>     CALCIUM CARBONATE, PRECIPITATED; FAMOTIDINE; MAGNESIUM HYDROXIDE>D>       TABLET, CHEWABLE; ORAL>D>         PEPCID COMPLETE>D>       +   MERCK                      800MG;10MG;165MG                        N20958 001  Oct 16, 2000    Aug  CAIN>A>     CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE>A>       TABLET, CHEWABLE; ORAL>A>         PEPCID COMPLETE>A>       +   MERCK                      800MG;10MG;165MG                        N20958 001  Oct 16, 2000    Aug  CAIN        LOPERAMIDE HYDROCHLORIDE>A>       CAPSULE; ORAL>A>         LOPERAMIDE HCL>A>           BANNER                     1MG                                     N21855 001  Aug 04, 2005    Aug  NEWA>A>       +                              2MG                                     N21855 002  Aug 04, 2005    Aug  NEWA   


Need An Actoplus Met Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact an Actoplus Met attorney in District of Columbia?...Get a free case evaluation from one of our Actoplus Met attorneys in District of Columbia now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Actoplus Met Case - Submit Your Information Below

Do you need legal assistance with your Actoplus Met case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * FDA Drug Database: Actoplus Met Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.